The Use of Oncept Melanoma Vaccine in Veterinary Patients: A Review of the Literature
The Oncept melanoma vaccine is xenogeneic DNA vaccine targeting tyrosinase. It is USDA approved for treatment of stage II to III canine oral melanoma and is also used off-label for melanomas arising in other locations and in other species. While the vaccine appears safe, the published data is mixed...
Main Author: | MacKenzie A. Pellin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/9/11/597 |
Similar Items
-
Vet-OncoNet: Developing a Network of Veterinary Oncology and Reporting a Pioneering Portuguese Experience
by: Katia Pinello, et al.
Published: (2022-02-01) -
Cancerogenic parasites in veterinary medicine: a narrative literature review
by: Niccolò Fonti, et al.
Published: (2023-07-01) -
Circulating Melanoma-Derived Extracellular Vesicles: Impact on Melanoma Diagnosis, Progression Monitoring, and Treatment Response
by: Stephanie M. Bollard, et al.
Published: (2020-12-01) -
Spinal meningeal melanocytoma in a 5-year-old child: a case report and review of literature
by: Ahmed M. Salah El-Din, et al.
Published: (2018-05-01) -
Investigation of differentially expressed genes that contribute to therapeutic effects of bevacizumab in BRAF mutant melanoma
by: Coupe, N
Published: (2020)